Antimicrobial activity of NM 394, an active form of prulifloxacin, against clinical isolates of Pseudomonas aeruginosa with a type II topoisomerase mutation

Minako Araake, Mariko Tani, Kazunori Maebashi, Tetsuro Hara, Hiroomi Watabe, Hiroshi Takahashi, Yutaka Tokue, Shigeru Fujimura, Kazunori Gomi, Akira Watanabe

    Research output: Contribution to journal › Review article › peer-review

    Fingerprint

    Dive into the research topics of 'Antimicrobial activity of NM 394, an active form of prulifloxacin, against clinical isolates of Pseudomonas aeruginosa with a type II topoisomerase mutation'. Together they form a unique fingerprint.

    Biochemistry, Genetics and Molecular Biology